Non-Hodgkin Lymphoma: Collaborating With Your Care Team

While PET scans have been used to predict Hodgkin lymphoma outcomes, adding Adcetris to frontline therapy improved outcomes for patients, regardless of their results.

‘Forwards,’ the new album by Mike Peters and the Alarm, was written while he was hospitalized for treatment of chronic lymphocyte leukemia and pneumonia.

Beginning in the long, cold winter of 2022, I began a series of hospitalizations to treat my stage 2 non-specific non-Hodgkin Lymphoma. For the next six months, I would spend a week in the hospital every single month.

Dr. Dawn Mussallem of the Mayo Clinic tells CURE®’s “Cancer Horizons” podcast about how surviving stage 4 non-Hodgkin’s lymphoma and being a heart transplant recipient helps her connect with her patients.

The Food and Drug Administration accepted a supplemental New Drug Application for Brukinsa plus Gazyva to treat patients with relapsed or refractory follicular lymphoma.

I will continue to say that I am a “survivor,” and that is the best title I could ever receive.